Moreover, a history of prior curative surgery showed a trend toward improved OS, although it did not reach statistical significance (HR = 0.65; 95% CI, 0.40–1.05; p = 0.080).
← all excerpts
Liposomal irinotecan with fluorouracil and leucovorin as salvage treatment for advanced biliary tract cancer refractory to gemcitabine and cisplatin.
1
—
—